Inventor · disambiguated record
Fabrizio Comper
Also filed as: COMPER FABRIZIO
3 granted patents·7 pending applications·2 citations·filing 2013–2025
55Inventor score
Top patents by PatentIndex Score
10 records- 0179US11097010B2In vivo methods for selecting peptides that cross the blood brain barrier, related compositions and methods of useOSSIANIX INC·Filed 2017·Granted Aug 24, 2021·2 cites·19 claims
- 0273US2024050581A1In vivo methods for selecting peptides that cross the blood brain barrier, related compositions and methods of useOSSIANIX INC·Filed 2023·Application pending·0 cites
- 0368US11766482B2In vivo methods for selecting peptides that cross the blood brain barrier, related compositions and methods of useOSSIANIX INC·Filed 2021·Granted Sep 26, 2023·0 cites·12 claims
- 0467US12258414B2Anti-CD98hc VNARs for crossing the blood brain barrier and type IV VNAR librariesOSSIANIX INC·Filed 2019·Granted Mar 25, 2025·0 cites·16 claims
- 0566US2025263502A1Anti-CD98hc VNARs for Crossing the Blood Brain Barrier and Type IV VNAR LibrariesOSSIANIX INC·Filed 2025·Application pending·0 cites
- 0659US2020010568A1Purification of hetero-dimeric immunoglobulinsGLENMARK PHARMACEUTICALS SA·Filed 2019·Application pending·0 cites
- 0756US2022396611A1Factor viii constructFREELINE THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 0854US2022396610A1Factor viii polypeptideFREELINE THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 0952US2015239991A1Purification of hetero-dimeric immunoglobulinsGLENMARK PHARMACEUTICALS SA·Filed 2013·Application pending·0 cites
- 1050US2024261433A1PolypeptideFREELINE THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Fabrizio Comper files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →